Abberger H, Barthel R, Bahr J, Thiel J, Luppus S, Buer J, Westendorf AM, Hansen W. Neuropilin-1 Is Expressed on Highly Activated CD4+ Effector T Cells and Dysfunctional CD4+ Conventional T Cells from Naive Mice.  J Immunol. 2021 Aug 2:ji2100222. doi: 10.4049/jimmunol.2100222. Online ahead of print.


Ngo Thi Phuong N, Palmieri V, Adamczyk A, Klopfleisch R, Langhorst J, Hansen W, Westendorf AM, Pastille E.  IL-33 Drives Expansion of Type 2 Innate Lymphoid Cells and Regulatory T Cells and Protects Mice From Severe, Accute Colitis.  Front Immunol. 2021 12:669787. doi: 10.3389/fimmu.2021.669787.

Budeus B, Kibler A, Brauser M, Homp E, Bronichewski K, Ross AJ, Görgens A, Weniger MA, Dunst J, Kreslavsky T, Vitoriano da Conceicao Castro S, Murke F, Oakes CC, Rusch P, Andrikos D, Kern P, Köninger A, Lindemann M, Johansson P, Hansen W, Lundell A-C, Rudin A, Dürig J, Giebel B, Hoffmann D, Küppers R, Seifert M (2021) Human Cord Blood B Cells Differ from the Adult Counterpart by Conserved lg Repertoires and Accelerated Response Dynamics. J Immunol 2021 Jun 11; ji2100113. doi: 10.4049/jimmunol.2100113. Online ahead of print.


Adamczyk A, Pastille E, Kehrmann J, Vu VP, Geffers R, Wasmer MH, Kasper S, Schuler M, Lange CM, Mgugli B, Rau TT, Klein D, Hansen W, Krebs P, Buer J, Westendorf AM. GPR15 facilitates Recruitment of Regulatory T cells to Promote Colorectal Cancer. Cancer Res. 2021 Jun 1;81(11)2970-2982.


Palmieri V, Ebel JF, Ngo Thi Phuong N, Klopfleisch R, Vu VP, Adamczyk A, Zöller J, Riedel C, Buer J, Krebs P, Hansen W, Pastille E, Westendorf AM. Interleukin-33 signaling exacerbates experimental infectious colitis by enhancing gut permeability and inhibiting protective Th17 immunity.  Mucosal Immunol. 2021 Mar 2. doi: 10.1038/s41385-021-00386-7. Online ahead of print



Hansen W, Luppus S, Barthel R, Chang DI, Broemstrup J, Zwarg T, Shibata, Westendorf AM, Buer J, Scherbaum N. Heroin-assisted treatment of heroin-addicted patients normalizes regulatroy T cells but does not restore CD4+ T cell proliferation. Addict Biol. 2020 Dec 17:e 12998. doi: 10.1111/adb 12998.


Zöller J, Ebel J-F, Khairnar V, Schmitt V, Klopfleisch R, Meiners J, Seiffert V, Hansen W, Buer J, Singer BB, Lang KS, Westendorf AM. CEACAM1 regulates CD8 T cell immunity and protects from severe pathology during Citrobacter rodentium induced colitisJune 10, 2020. Gut Microbes 2020; 11(6): 1790-1805


Liedtke K, Alter C, Günther A, Hövelmeyer N, Klopfleisch R, Naumann R, Wunderlich FT, Buer J, Westendorf AM, Hansen W. Endogenous CD83 Expression in CD4+   Conventional T Cells Controls Inflammatory Immune Responses. J Immunol 2020; 204(12): 3217-3226.





Plöhn S, Hose M, Schlüter A, Michel L, Diaz-Cano SJ, Hendgen-Cotta U, Banga JP, Bechrakis N, Hansen W, Eckstein A, Berchner-Pfannschmidt U. Fingolimod improves the outcome of experimental Graves' disease and associated orbitopathy by modulating the autoimmune response to the thyroid stimulating hormone receptor. Thyroid 2019; 29: 1286-1301.


Hose M, Günther A, Abberger H, Begum S, Korencak M, Becker KA, Buer J, Westendorf AM, Hansen W. T Cell-specific overexpression of acid sphingomyelinase results in elevated T Cell activation and reduced parasitemia during plasmodium yoelii Infection. Front Immunol, 2019; 10: 1225.


Meiners M, Palmieri V, Klopfleisch R, Ebel JF, Japtok L, Schumacher F, Yusuf AM, Becker K.A., Zöller J, Hose M, Kleuser B, Hermann DM, Kolesnick R, Buer J, Hansen W, Westendorf A M. Intestinal acid sphingomyelinase protects from severe pathogen driven colitis. Front Immunol. 2019; 10: 1386.


Pastille E, Wasmer MH, Adamczyk A, Vu VP, Mager LF, Phuong NNT, Palmieri V, Simillion C, Hansen W, Kasper S, Schuler M, Muggli B, McCoy KD, Buer J, Zlobec I, Westendorf AM, Krebs P. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer. Mucosal Immunol. 2019; 12: 990-1003.


Heße C, Kollenda S, Rotan O, Pastille E, Adamczyk A, Wenzek C, Hansen W, Epple M, Buer J,Westendorf AM, Knuschke T. A tumor-peptide based nanopaticle vaccine elicits efficient tumor growth control in anti-tumor immunotherapy. Mol Cancer Ther 2019; 18: 1069-80.


Verhasselt HL, Radke J, Schmidt D, Killengray D, Scharmann U, Rickerts V, Hansen W, Seidel D, Falces-Romero I, Buer J, Rath PM, Steinmann J. Comparison of genotyping methods for Cunninghamella bertholletiae. Mycoses. 2019; 62: 519-25. 


Schulte-Mecklenbeck A, Kleffner I, Beuker C, Wirth T, Hartwig M, Schmidt-Pogoda A, Klotz L, Hansen W, Wiendl H, Meuth SG, Gross CC, Minnerup J. Immunophenotyping of cerebrospinal fluid cells in ischaemic stroke. Eur J Neurol 2019; 26: 919-26.





Plöhn S, Edelmann B, Japtok L, He X, Hose M, Hansen W, Schuchman EH, Eckstein A, Berchner-Pfannschmidt U. CD40 Enhances Sphingolipids in Orbital Fibroblasts: Potential Role of Sphingosine-1-Phosphate in Inflammatory T-Cell Migration in Graves' Orbitopathy. Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5391-5397. doi: 10.1167/iovs.18-25466.

Thiel J, Alter C, Luppus S, Eckstein A, Tan S, Führer D, Pastille E, Westendorf AM, Buer J, Hansen W. MicroRNA-183 and microRNA-96 are associated with autoimmune responses by regulating T cell activation. J Autoimmun. 2018 Sep 7. pii: S0896-8411(18)30302-0. doi: 10.1016/j.jaut.2018.08.010. [Epub ahead of print]

Herz J, Köster C, Crasmöller M, Abberger H, Hansen W, Felderhoff-Müser U, Bendix I. Peripheral T cell depletion by FTY720 exacerbates hypoxic-ischemic brain injury in neonatal mice. Front Immunol. 2018 Aug 6;9:1696.doi: 10.3389/fimmu.2018.01696

Herz J, Köster C, Reinboth BS, Dzietko M, Hansen W, Sabir H, van Velthoven C, Bendix I, Felderhoff-Müser U. Interaction between hypothermia and delayed mesenchymal stem cell therapy in neonatal hypoxic-ischemic brain injury. Brain Behav Immun 2018 May;70:118-130. doi: 10.1016/j.bbi.2018.02.006.

Knuschke T, Rotan O, Bayer W, Kollenda S, Dickow J, Sutter K, Hansen W, Dittmer U, Lang KS, Epple M, Buer J, Westendorf AM. Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination IsIndispensable to Reinforce Cytotoxic CD8+ T Cell Responses During Chronic Retroviral Infection.Front Immunol. 2018 Apr 23;9:614.doi: 10.3389/fimmu.2018.00614.

Batzke K, Büchel G, Hansen W, Schramm A. TrkB-Target Galectin-1 Impairs immune Activation and Radiation Responses in Neuroblastoma: Implications for Tumour Therapy. Int J Mol Sci 2018 Mar 2;19(3). pii: E718. doi: 10.3390/ijms19030718



Smirnov A; Pohlmann S; Nehring M; Ali S; Mann-Nüttel R; Scheu S; Antoni AC; Hansen W; Büttner M; Gardiasch M; Westendorf A; Wirsdörfer F; Pastille E; Dudda M; Flohé S. Sphingosine 1-phosphate-and CCR2-dependent activation of CD4+ plasmacytoid dendritic cells in the bone marrow contributes to signs of Sepsis-Induced immunosuppression. Front. Immunol. 2017 Nov 23:


Ueffing K.; Abberger H.; Westendorf A.M.; Matuschewski K.; Buer J.; Hansen W. Conventional CD11c high dendritic cells are essential for T cell priming during the initial phase of plasmodium yoelii infection, but are dispensable at later time points. Front Immunol 5:1333. doi: 10.3389/fimmu.2017.01333.


Pastille E.; Frede A.; McSorley H.; Gräb J.; Adamczyk A.; Kollenda S.; Hansen W.; Epple M.; Buer J. Maizels R.M.; Klopfleisch R.; Westendorf A.M. Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer. PlosPathogens 2017; 13 (9): e1006649. doi: 10.1371/Journal.ppat.1006649.


Frede A.; Neuhaus B.; Knuschke T.; Wadwa M.; Kollenda S.; Klopfleisch R.; Hansen W.; Buer J.; Bruder D.; Epple M.; Westendorf A.M. Local delivery of siRNA-loaded calcium Phosphate nanopartiles abates pulmonary Inflammation. Nanomedicine 2017; 13: 2395-2403. doi: 10.1016/j.nano.2017.08.001.


Adamczyk A.; Gageik D.; Frede A.; Pastille E.; Hansen W.; Rueffer A.; Buer J.; Büning J.; Langhost J.; Westendorf A.M. Differential expression of GPR15 on T cells during ulcerative colitis. JCI Insight. 2017; 2(8). pii: 90585. doi: 10.1172/jci.insight.90585.  


Westendorf A.M.; Skibbe K.; Adamczyk A.; Buer J.; Geffers R.; Hansen W.; Jendrossek V.; Hypoxia Enhances Immunosuppression by Inhibiting CD 4+Effector T Cell Function and Promoting Treg Activity. Cell Physiol Biochem 2017; 41: 1271-1284. doi: 10.1159/000464429. 


Loevenich K.; Ueffing K.; Abel S.; Hose M.; Matuschewski K.; Westendorf A.M.; Buer J.; Hansen W. DC-Derived IL-10 Modulates Pro-inflammatory Cytokine production and Promotes Induction of CD4+ IL-10 10+ Regulatory T cells during Plasmodium yoelii Infection. Front Immunol. 2017; 8:152. doi 10.3389/fimmu. 2017.00152.



Gamrad, L.; Rehbock, C.; Westendorf, A.M.; Buer, J.; Hansen, W. 2016. Efficient nucleic acid delivery to murine regulatory T cells by gold nanoparticle conjugates. Sci Rep 6: 28709.


Buechel, G.; Schulte, J.H.; Harrison, L.; Schüller, U.; Hansen, W.; Schramm, A. (2016). Immune response modulation by Galectin-1 in a transgenic model of neuroblastoma. Oncoimmunology 5:e113178.


Knuschke T , Rotan  O, Bayer  W, Sokolova  V, Hansen  W, Sparwasser  T, Dittmer  U, Epple M, Buer  J, Westendorf  AM. 2016. Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection. Retrovirology 13:24


Wadwa M, Klopfleisch R, Adamczyk A, Frede A, Pastille E, Mahnke K, Hansen W, Geffers R, Lang KS, Buer J, Büning J, Westendorf AM. 2016. IL-10 downregulates CXCR3 expression on Th1 cells and interferes with their migration to intestinal inflammatory sites. Mucosal Immunol. 9:1263-77.


Abel S, Ueffing K, Tatura R, Hutzler M, Hose M, Matuschewski K, Kehrmann J, Westendorf AM, Buer J, Hansen W. 2016. Plasmodium yoelii infection of BALB/c mice results in expansion rather than induction of CD4+ Foxp3+ regulatory T cells. Immunology 148: 197-205.


Berchner-Pfannschmidt U, Moshkelgosha S, Diaz-Cano S, Edelmann B, Görtz GE, Horstmann M, Noble A, Hansen W, Eckstein A, Banga JP. 2016. Comparative Assessment of Female Mouse Model of Graves' Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen. Endocrinology 157: 1673-82.


Serdar M, Herz J, Kempe K, Lumpe K, Reinboth BS, Sizonenko SV, Hou X, Herrmann R, Hadamitzky M, Heumann R, Hansen W, Sifringer M, van de Looij Y, Felderhoff-Müser U, Bendix I. 2016. Fingolimod protects against neonatal white matter damage and long-term cognitive deficits caused by hyperoxia. Brain Behav Immun. 52: 106-19.


Seifert V, Zoeller J, Klopfeisch R, Wadwa M, Hansen W, Buer J, Riedel C, Westendorf AM 2015. IL10-Deficiency in CD4*T Cells Exacerbates the IFNy and IL17 Response During Baceteria Induced Colitis. Cell Physiol Biochem 36: 1259-73.

Tatura R, Zeschnigk M, Hansen W, Steinmann J, Vidigal PG, Hutzler M, Pastille E, Westendorf AM, Buer J, Kehrmann J. 2015. Relevance of Foxp3⁺ regulatory T cells for early and late phases of murine sepsis. Immunology 146: 144-56.


Niezold T, Storcksdieck Genannt Bonsmann M, Maaske A, Temchura V, Heinecke V, Hannaman D, Buer J, Ehrhardt C, Hansen W, Überla K, Tenbusch M. 2015. DNA vaccines encoding DEC205-targeted antigens: immunity or tolerance? Immunology 145: 519-33.


Wirsdörfer F, Bangen JM, Pastille E, Hansen W, Flohé SB. 2015. Breaking the co-operation between bystander T-cells and natural killer cells prevents the development of immunosuppression after traumatic skeletal muscle injury in mice. Clin Sci 128: 825-38.



Jost, N.H., S. Abel, M. Hutzler, T. Sparwasser, A. Zimmermann, A. Roers, W.  Müller, R. Kopfleisch, H. Hengel, AM. Westendorf, J. Buer and W. Hansen. 2014. Regulatory T cells and T-cell-derived IL-10 interfere with effective anti-cytomegalovirus immune response. Immunology and Cell Biology. 92:860-71.


Knuschke, T., W. Bayer, O. Rotan, V. Sokolova, M. Wadwa, CJ. Kirschning, W. Hansen, U. Dittmer, M. Epple, J. Buer and A.M. Westendorf. 2014. Prophylactic and therapeutic vaccination with a nanoparticle-based peptide vaccine induces efficient protecitve immunity during acute and chronic retroviral infection. Nanomedicine. 10:1787-98


Pastille, E., K. Bardini, D. Fleissner, A. Adamczyk, A. Frede, M. Wadwa, D. von Smolinski, S. Kasper, T. Sparwasser, A.D. Gruber, M. Schuler, S. Sackaguchi, A. Roers, W. Muller, W. Hansen, J. Buer and A.M. Westendorf. 2014. Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res. 74:4258-69



Herz, J., S.I, Hagen, E. Bergmüller, P. Sabellek, J.R. Göthert, J. Buer, W. Hansen, D.M. Hermann, and T, Doeppner. 2013. Exacerbation of ischemic brain injury in hypercholesterolemic mice is associated with pronounced changes in peripheral and cerebral immune responses. Neurobiol. Dis. 62C: 456-68.


Knuschke, T., V. Sokolova, O. Rotan, M. Wadwa, M. Tenbusch, W. Hansen, P. Staeheli, M. Epple, J. Buer and A.M. Westendorf. 2013. Immunization with biodegradable nanoparticles efficiently induces cellular immunity and protects against influenza virus infection. J. Immunol. 190:6221-9.


Hansen, W. 2013. Neuropilin-1 guides regulatory T cells into VEGF-producing melanoma. Oncolmmunology. 2: e23039.



Jeron, A., W. Hansen, J. Buer, R. Geffers and D. Bruder. 2012. ChIP-on-Chip analysis identifies IL-22 as direct target gene of ectopically expressed FOXP3 transcription factor in human T cells. BMC Genomics 13: 705.


Hansen, W., M. Hutzler, S. Abel, C. Alter, C. Stockmann, S. Kliche, J. Albert, T. Sparwasser, S. Sakaguchi, A.M. Westendorf, D. Schadendorf, J. Buer and I. Helfrich. 2012. Neuropilin-1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth. J. Exp. Med. 209: 2001-16.


Riß, G.-L., D.-I. Chang, O. Zafiris, A.M. Westendorf, J. Buer, N. Scherbaum, and W. Hansen. 2012. Opioid maintenance therapy restores CD4+ T cell function by normalizing CD4+CD25high regulatory T cell frequencies in heroin user. Brain Behav Immun 26: 972-8.


Abel, S., N. Lückheide, A.M. Westendorf, R. Geffers, A. Roers, W. Mueller, T. Sparwasser, K. Matuschewski, J. Buer and W. Hansen. 2012. Strong impact of CD4+Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection. J. Immunol. 188: 5467-77.



Fleissner, D., K. Loser, W. Hansen, J. Dissemond, A. Körber, S. Beissert, J. Buer and A.M. Westendorf. 2011. In vitro induced CD8+ regulatory T cells inhibit skin inflammation. Eur J Microbiol Immunol 1: 208–214.


Fleissner, D., A. Frede, M. Knott, T. Knuschke, R. Geffers, W. Hansen, G. Dobos, J. Langhorst, J.  Buer, A.M. Westendorf. 2011. Generation and function of immunosuppressive human and murine CD8+ T cells by TGF-β and retinoid acid. Immunology 134: 82-92.



Fleissner, D., W. Hansen, R. Geffers, J. Buer, J. and Westendorf, A.M. 2010. Local induction of immunosuppressive CD8+ T cells in the gut associated lymphoid tissues. PLOS One 5: e15373.


Hansen, W., A.M. Westendorf, T. Toepfer, S. Mauel, A.D. Gruber, R. Geffers and J. Buer. 2010. Inflammation in vivo is modulated by GPR83 isoform-4 but not GPR83 isoform-1 expression in regulatory T cells. Genes Immun. 11: 357-361.      


Bendix, I., C.F. Pfueller, T. Leuenberger, N. Glezeva, V. Siffrin, Y. Muller, T. Prozorovski, W. Hansen, U. Schulze-Topphoff, C. Loddenkemper, F. Zipp, and S. Waiczies. 2010. MAPK3 deficiency drives autoimmunity via dendritic cell arming. Eur. J. Immunol. 40: 1486-1495.


Westendorf, A.M., D. Fleissner, W. Hansen and J. Buer. 2010. T cells, dendritic cells and epithelial cells in intestinal homeostasis. Int. J. Med. Microbiol. 300: 11-18.



Westendorf, A.M., D. Fleissner, L. Groebe, S. Jung, A.D. Gruber, W. Hansen and J. Buer. 2009. CD4+Foxp3+ regulatory T cell expansion induced by antigen-driven CD4+Foxp3+ interaction with intestinal epithelial cells independent of local dendritic cells. Gut 58: 211-219.



Hansen, W., A.M. Westendorf, and J. Buer. 2008. Regulatory T cells as targets for immunotherapy of autoimmunity and inflammation. Inflamm Allergy Drug Targets 7: 217-223.


S. Reinwald, C. Wiethe, A. M. Westendorf, M. Breloer, M. Probst-Kepper, B. Fleischer, A. Steinkasserer, J. Buer and W. Hansen. 2008. CD83 expression in CD4+ T cells modulates inflammation and autoimmunity. J. Immunol. 180: 5890-5897.



Ukena, S.N., A. Singh, U. Dringenberg, R. Engelhardt, U. Seidler, W. Hansen, A. Bleich, D. Bruder, A. Franzke, G. Rogler, S. Suerbaum, J. Buer, F. Gunzer and A.M. Westendorf. 2007. Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity. PLoS ONE 12, e1308


Hansen, W., A.M. Westendorf, S. Reinwald, D. Bruder, S. Deppenmeier, L. Groebe, M.  Probst-Kepper, A.D. Gruber, R. Geffers and J. Buer. 2007. Chronic antigen stimulation in vivo induces a distinct population of antigen-specific Foxp3lowCD25- regulatory T cells. J. Immunol. 179: 8059-8068.



Westendorf, A.M., D. Bruder, W. Hansen and J. Buer. 2006. Intestinal epithelial antigen induces CD4+ T cells with regulatory phenotype in transgenic autoimmune mouse model. Ann. N.Y. Acad. Sci. 1072: 401-406.


Pfoertner, S., A. Jeron, M. Propst-Kepper, C.A. Guzman, W. Hansen, A.M. Westendorf, T.  Toepfer, A.J. Schrader, A. Franzke, J. Buer and R. Geffers. 2006. Signatures of Human Regulatory T Cells: An Encounter with Old Friends and New Players. Genome Biology 7: R54.1-54.18.


A.M. Westendorf, D. Fleisser, S. Deppenmeier, A.D. Gruber, D. Bruder, W. Hansen, R. Liblau and J. Buer. 2006. Autoimmune mediated intestinal inflammation – impact and regulation of antigen specific CD8+ T cells. Gastroenterology 131: 510-524.


Hansen, K. Loser, A.M. Westendorf, D.  Bruder, C. Siewert, J. Huehn, S. Beissert and J. Buer . 2006. GPR83-overexpression in naïve CD4+CD25- T cells leads to the induction of Foxp3+ regulatory T cells in vivo. J.Immunol. 177: 209-215.


De Buhr, M., M. Mahler, R. Geffers, W. Hansen, A.M. Westendorf, J. Lauber, J. Buer, S. Akira, B. Schlegelberger, H.J. Hedrich and A. Bleich. 2006. CD14, Gbp1, and Pla2g2a: 3 major candidate genes for experimental IBD identified by combining QTL and microarray analyses. Physiol. Genomics 25: 426-422.


Veldman, C., A. Pahl, S. Beissert, W. Hansen, J. Buer, D. Dieckmann, G. Schuler and M. Hertl. 2006. Inhibition of the Transcription Factor Foxp3 converts Desmoglein 3-Specific Type 1 Regulatory T Cells into Th2-Like T cells. J.Immunol. 176: 3215-3222.



Ukena, S.N., A.M. Westendorf, W. Hansen, M. Rohde, R. Geffers, S. Coldewey, S. Suerbaum, J. Buer, and F. Gunzer. 2005. The host response to the probiotic Escherichia coli strain Nissle 1917: Specific up-regulation of the proinflammatory chemokine MCP-1. BMC Medical Genetics 6: 43-55.


Buer, J., A.M. Westendorf, A.-P. Zeng, F. He, W. Hansen, and M. Probst-Kepper. 2005. Mechanisms of central and peripheral T cell tolerance: An update. Transfusion Medicine and Hemotherapy 32: 384-399.


Bruder, D, A.M. Westendorf, W. Hansen, S. Prettin, A.D. Gruber, Y. Qian, H. von Boehmer, K. Mahnke and J. Buer. 2005. On the edge of autoimmunity: T cell Stimulation by Steady-State Dendritic Cells Prevents Autoimmune Diabetes. Diabetes 54: 3395-3401.


Pfoertner, S., U. Goelden, W. Hansen, T. Toepfer, R. Geffers, S.N. Ukena, R. von Knobloch, R. Hofmann, J. Buer and AJ. Schrader. 2005. Cellular Retinoic Acid Binding Protein I: Expression and Functional Influence in Renal Cell Carcinoma. Tumor Biology 26: 313-323.


Goelden, U., S. Pfoertner, W. Hansen, T. Toepfer, R. von Knobloch, R. Hofmann, J. Buer and AJ. Schrader. 2005. Expression and Functional Influence of Cellular Retinoic Acid-Binding Protein II in Renal Cell Carcinoma. Urologia Internationalis 75: 269-276.


Loser, K., W. Hansen, J. Apelt, S. Balkow, J. Buer and S. Beissert. 2005. In vitro generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact hypersensitivity and systemic autoimmunity. Gene Therapy 12: 1294-1304.


Hansen, W., E. Grabenhorst, M. Nimtz, K. Müller, H.S.Conradt and M. Wirth. 2005. Generation of serum-stabilized retroviruses: Reduction of a1,3-gal-epitope synthesis in a murine NIH3T3-derived packaging cell line by expression of chimeric glycosyltransferases. Metabolic Engineering 7: 221-228.


Westendorf A.M., M. Templin, R. Geffers, S. Deppenmeier, A.D. Gruber, M. Probst-Kepper, W. Hansen, R.S. Liblau, F. Gunzer, D. Bruder and J. Buer. 2005. CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation. Gut 54: 60-69.



Hansen, W. and J. Buer. 2004. Role of regulatory T cells for the outcome of the allo- and autoimmune response. Transfusion Medicine and Hemotherapy 31: 322-331.


Bruder, D., M. Probst-Kepper, A.M. Westendorf, R. Geffers, S. Beissert, K. Loser, H. von Boehmer, J. Buer and W. Hansen. 2004. Neuropilin-1 – a surface marker of regulatory T-cells. Eur. J. Immunol. 34: 623-630.



Franzke, A., W. Piao, J. Lauber, P. Gatzlaff, C. Könecke, W. Hansen, A. Schmitt-Thomsen, B. Hertenstein, J. Buer and A. Ganser. 2003. G-CSF as immune regulator in T-cells expressing G-CSF receptor: Implications for transplantation and autoimmune diseases, Blood 102: 734-739.


Matussek, A., J. Lauber, A. Bergau, W. Hansen, M. Rohde, K. E. J. Dittmar, M. Gunzer, M. Mengel, P. Gatzlaff, M. Hartmann, J. Buer, and F. Gunzer. 2003. Molecular and functional analysis of Shiga toxin induced response patterns in human vascular endothelial cells. Blood 102: 1323-1332.


GPR15 facilitates recruitment of regulatory T cells to promote colorectal Cancer. Cancer Res. 2021 Mar16:canres.2133.2020. doi:10.1158/0008-5472.CAN-20-2133.Online ahead of print.